Amarin issued the following statement in response to Sarissa’s latest misstatements regarding the company’s management compensation: "The Amarin Board of Directors, consistent with standard public company practice and in line with its fiduciary responsibilities, authorized its management compensation plan for 2023. Contrary to Sarissa’s claims, the timing of the plan approval was in February, which is consistent with previous years. In addition, as part of this year’s compensation plan (like all prior years), all Amarin employees globally received annual performance grants. Sarissa’s comment that Karim Mikhail’s equity grants vest "solely based on the passage of time" is also another misrepresentation of the facts. Mr. Mikhail’s compensation package includes performance-based grants, which are only triggered if performance thresholds are achieved. Sarissa also insinuates that the Board is "refusing" to release the results of the General Meeting – this is another misrepresentation of the facts. The General Meeting has not occurred yet, and Sarissa and its legal advisors both know that companies do not publicize preliminary results prior to any general meeting, consistent with SEC guidelines. The Board assures shareholders that the results of the General Meeting will be posted in a timely manner following the conclusion of the meeting. The New Amarin is on the right track toward transforming into a global, diversified cardiometabolic player as we execute a thoughtful and practical strategic plan designed to create value now."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AMRN:
- Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders
- Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand
- Amarin Sets the Record Straight on Sarissa’s Latest Misstatements
- Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC
- Amarin holder Sarissa discloses ‘egregious’ equity grants to executives